223 related articles for article (PubMed ID: 29452653)
21. Postinflammatory hyperpigmentation in patients with skin of color.
Shokeen D
Cutis; 2016 Jan; 97(1):E9-E11. PubMed ID: 26919365
[TBL] [Abstract][Full Text] [Related]
22. The effect of menstrual cycle on laser induced hyperpigmentation.
Al Mohizea S
J Drugs Dermatol; 2013 Dec; 12(12):1335-6. PubMed ID: 24301233
[TBL] [Abstract][Full Text] [Related]
23. Dynamic evaluation of an in vivo postinflammatory hyperpigmentation model using reflectance confocal microscopy and spectrophotometry.
Zhao J; Liu Z; Zhang C; Wu J; Huang N; Du Y; Xiang L
J Cosmet Dermatol; 2021 Sep; 20(9):2950-2962. PubMed ID: 33394548
[TBL] [Abstract][Full Text] [Related]
24. The Yucatan miniature swine as a model for post-inflammatory hyperpigmentation.
Wang Y; Herringshaw E; Anderson RR; Tam J
Pigment Cell Melanoma Res; 2024 May; 37(3):403-410. PubMed ID: 38361478
[TBL] [Abstract][Full Text] [Related]
25. Postinflammatory hyperpigmentation.
Nordlund JJ
Dermatol Clin; 1988 Apr; 6(2):185-92. PubMed ID: 2454174
[TBL] [Abstract][Full Text] [Related]
26. Combination of In-Office Chemical Peels With a Topical Comprehensive Pigmentation Control Product in Skin of Color Subjects With Facial Hyperpigmentation.
Downie J; Schneider K; Goberdhan L; Makino ET; Mehta RC
J Drugs Dermatol; 2017 Apr; 16(4):301-306. PubMed ID: 28403262
[TBL] [Abstract][Full Text] [Related]
27. Hyperpigmentation Disorders in Hispanic Population in the United States.
Rendon MI
J Drugs Dermatol; 2019 Mar; 18(3):s112-114. PubMed ID: 30909363
[TBL] [Abstract][Full Text] [Related]
28. Management of post-inflammatory hyperpigmentation in skin of color: A short review.
Anvery N; Christensen RE; Dirr MA
J Cosmet Dermatol; 2022 May; 21(5):1837-1840. PubMed ID: 35289059
[TBL] [Abstract][Full Text] [Related]
29. Hyperpigmentation Disorders in Hispanic Population in the United States.
Rendon MI
J Drugs Dermatol; 2019 Mar; 18(3):s112-114. PubMed ID: 30909362
[TBL] [Abstract][Full Text] [Related]
30. cAMP-dependent activation of protein kinase A as a therapeutic target of skin hyperpigmentation by diphenylmethylene hydrazinecarbothioamide.
Shin H; Hong SD; Roh E; Jung SH; Cho WJ; Park SH; Yoon DY; Ko SM; Hwang BY; Hong JT; Heo TY; Han SB; Kim Y
Br J Pharmacol; 2015 Jul; 172(13):3434-45. PubMed ID: 25766244
[TBL] [Abstract][Full Text] [Related]
31. Optimal management of recalcitrant disorders of hyperpigmentation in dark-skinned patients.
Stratigos AJ; Katsambas AD
Am J Clin Dermatol; 2004; 5(3):161-8. PubMed ID: 15186195
[TBL] [Abstract][Full Text] [Related]
32. The ultraviolet B inflammation model: Postinflammatory hyperpigmentation and validation of a reduced UVB exposure paradigm for inducing hyperalgesia in healthy subjects.
Siebenga PS; van Amerongen G; Klaassen ES; de Kam ML; Rissmann R; Groeneveld GJ
Eur J Pain; 2019 May; 23(5):874-883. PubMed ID: 30597682
[TBL] [Abstract][Full Text] [Related]
33. Putting it all on pigmentation: Heuristics of a bold and stochastic cell fate decision.
Xing J; Lee RE
Sci Signal; 2015 Oct; 8(397):fs17. PubMed ID: 26443702
[TBL] [Abstract][Full Text] [Related]
34. Post-Inflammatory Hyperpigmentation: A Review of Treatment Strategies.
Shenoy A; Madan R
J Drugs Dermatol; 2020 Aug; 19(8):763-768. PubMed ID: 32845587
[TBL] [Abstract][Full Text] [Related]
35. Postinflammatory Hyperpigmentation: Epidemiology, Clinical Presentation, Pathogenesis and Treatment.
Kaufman BP; Aman T; Alexis AF
Am J Clin Dermatol; 2018 Aug; 19(4):489-503. PubMed ID: 29222629
[TBL] [Abstract][Full Text] [Related]
36. Misconceptions of photoprotection in skin of color.
Taylor SC; Alexis AF; Armstrong AW; Chiesa Fuxench ZC; Lim HW
J Am Acad Dermatol; 2022 Mar; 86(3S):S9-S17. PubMed ID: 34942293
[TBL] [Abstract][Full Text] [Related]
37. Effectiveness, safety, and effect on quality of life of topical salicylic acid peels for treatment of postinflammatory hyperpigmentation in dark skin.
Joshi SS; Boone SL; Alam M; Yoo S; White L; Rademaker A; Helenowski I; West DP; Kundu RV
Dermatol Surg; 2009 Apr; 35(4):638-44; discussion 644. PubMed ID: 19400885
[TBL] [Abstract][Full Text] [Related]
38. Hydroquinone-free multimodal topical regimen for facial hyperpigmentation.
Foad MS; Winters E
J Drugs Dermatol; 2013 Mar; 12(3):S42-4. PubMed ID: 23545933
[TBL] [Abstract][Full Text] [Related]
39. A new in vitro method to predict in vivo photoprotection of skin hyperpigmentation induced by visible light.
Duteil L; Cadars B; Queille-Roussel C; Giraud I; Drulhon F; Graizeau C; Guyoux A; Passeron T
J Eur Acad Dermatol Venereol; 2022 Jun; 36(6):922-926. PubMed ID: 35224781
[TBL] [Abstract][Full Text] [Related]
40. Effective reduction of post-inflammatory hyperpigmentation with the tyrosinase inhibitor isobutylamido-thiazolyl-resorcinol (Thiamidol).
Roggenkamp D; Dlova N; Mann T; Batzer J; Riedel J; Kausch M; Zoric I; Kolbe L
Int J Cosmet Sci; 2021 Jun; 43(3):292-301. PubMed ID: 33559186
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
